DOES ADJUVANT THERAPY WORK IN COLON CANCER

被引:30
作者
MAYER, RJ
机构
关键词
D O I
10.1056/NEJM199002083220610
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:399 / 401
页数:3
相关论文
共 11 条
[1]  
AMERY WK, 1982, CURRENT CONCEPTS HUM, P585
[2]   ADJUVANT THERAPY OF POOR PROGNOSIS COLON CANCER WITH LEVAMISOLE - RESULTS OF AN EORTC DOUBLE-BLIND RANDOMIZED CLINICAL-TRIAL [J].
ARNAUD, JP ;
BUYSE, M ;
NORDLINGER, B ;
MARTIN, F ;
PECTOR, JC ;
ZEITOUN, P ;
ADLOFF, A ;
DUEZ, N .
BRITISH JOURNAL OF SURGERY, 1989, 76 (03) :284-289
[3]   A CONTROLLED EVALUATION OF RECENT APPROACHES TO BIOCHEMICAL MODULATION OR ENHANCEMENT OF 5-FLUOROURACIL THERAPY IN COLORECTAL-CARCINOMA [J].
BUROKER, TR ;
MOERTEL, G ;
FLEMING, TR ;
EVERSON, LK ;
CULLINAN, SA ;
KROOK, JE ;
MAILLIARD, JA ;
MARSCHKE, RF ;
KLAASSEN, DJ ;
LAURIE, JA ;
MOON, MD .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) :1624-1631
[4]  
BUYSE M, 1988, JAMA-J AM MED ASSOC, V259, P3571
[5]   TOXICITY OF LEVAMISOLE AND 5-FLUOROURACIL IN HUMAN-COLON CARCINOMA-CELLS [J].
GREM, JL ;
ALLEGRA, CJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (18) :1413-1417
[6]  
Janssen P A, 1976, Prog Drug Res, V20, P347
[7]   SURGICAL ADJUVANT THERAPY OF LARGE-BOWEL CARCINOMA - AN EVALUATION OF LEVAMISOLE AND THE COMBINATION OF LEVAMISOLE AND FLUOROURACIL [J].
LAURIE, JA ;
MOERTEL, CG ;
FLEMING, TR ;
WIEAND, HS ;
LEIGH, JE ;
RUBIN, J ;
MCCORMACK, GW ;
GERSTNER, JB ;
KROOK, JE ;
MALLIARD, J ;
TWITO, DI ;
MORTON, RF ;
TSCHETTER, LK ;
BARLOW, JF .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) :1447-1456
[8]   STATUS OF ADJUVANT THERAPY FOR COLORECTAL-CANCER [J].
MAYER, RJ ;
OCONNELL, MJ ;
TEPPER, JE ;
WOLMARK, N .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (18) :1359-1364
[9]   LEVAMISOLE AND FLUOROURACIL FOR ADJUVANT THERAPY OF RESECTED COLON-CARCINOMA [J].
MOERTEL, CG ;
FLEMING, TR ;
MACDONALD, JS ;
HALLER, DG ;
LAURIE, JA ;
GOODMAN, PJ ;
UNGERLEIDER, JS ;
EMERSON, WA ;
TORMEY, DC ;
GLICK, JH ;
VEEDER, MH ;
MAILLIARD, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) :352-358
[10]  
VERHAEGEN H, 1982, IMMUNOTHERAPY HUMAN, P225